Experimental Drug Might Stop Ebola

While the Ebola epidemic in West Africa and beyond has begun to wane, the race to find a drug to help fight, or prevent, another outbreak continues. Since there is no cure or vaccine for the virus, any progress on finding a treatment is a welcome sign. On Wednesday, a new study, while far from being conclusive, gave reason for optimism, as an experimental drug saved the lives of monkeys infected with the same strain of the virus that has led to the current outbreak.

The treatment, known as TKM-Ebola-Makona, is in the preliminary testing stage, and has not been proven to work on humans. During the trial, six rhesus monkeys were given a high dose of the virus and the half that were then administered TKM-Ebola-Makona survived. “All three treated monkeys survived despite fevers and enormous blood levels of virus,” according to Reuters. “Three untreated monkeys became so ill they were euthanized within nine days.”

This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the privacy policy.
By closing this banner, scrolling on this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.OkRead more